| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 264 | 2021 |
| Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin … U Rudloff, RC Langan, JE Mullinax, JD Beane, SM Steinberg, T Beresnev, ... Journal of surgical oncology 110 (3), 275-284, 2014 | 214 | 2014 |
| Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial BC Creelan, C Wang, JK Teer, EM Toloza, J Yao, S Kim, AM Landin, ... Nature medicine 27 (8), 1410-1418, 2021 | 210 | 2021 |
| Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma MD Jain, H Zhao, X Wang, R Atkins, M Menges, K Reid, K Spitler, ... Blood, The Journal of the American Society of Hematology 137 (19), 2621-2633, 2021 | 164 | 2021 |
| Current diagnosis and management of retroperitoneal sarcoma JE Mullinax, JS Zager, RJ Gonzalez Cancer Control 18 (3), 177-187, 2011 | 144 | 2011 |
| Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group CJ Swallow, DC Strauss, S Bonvalot, P Rutkowski, A Desai, RA Gladdy, ... Annals of surgical oncology 28, 7873-7888, 2021 | 125 | 2021 |
| Colorectal cancer biomarkers and the potential role of cancer stem cells RC Langan, JE Mullinax, MT Raiji, T Upham, T Summers, A Stojadinovic, ... Journal of Cancer 4 (3), 241, 2013 | 120 | 2013 |
| Label-retaining liver cancer cells are relatively resistant to sorafenib HW Xin, CM Ambe, DM Hari, GW Wiegand, TC Miller, JQ Chen, ... Gut 62 (12), 1777-1786, 2013 | 113 | 2013 |
| Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins J Hernandez, J Mullinax, W Clark, P Toomey, D Villadolid, C Morton, ... Annals of surgery 250 (1), 76-80, 2009 | 112 | 2009 |
| Combination of ipilimumab and adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic melanoma JE Mullinax, ML Hall, S Prabhakaran, J Weber, N Khushalani, Z Eroglu, ... Frontiers in oncology 8, 44, 2018 | 84 | 2018 |
| Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division HW Xin, DM Hari, JE Mullinax, CM Ambe, T Koizumi, S Ray, AJ Anderson, ... Stem cells 30 (4), 591-598, 2012 | 76 | 2012 |
| A pilot study assessing the potential role of non-CD133 colorectal cancer stem cells as biomarkers RC Langan, JE Mullinax, S Ray, MT Raiji, N Schaub, HW Xin, T Koizumi, ... Journal of cancer 3, 231, 2012 | 70 | 2012 |
| Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis W Clark, J Hernandez, B McKeon, D Villadolid, S Al-Saadi, J Mullinax, ... The American Surgeon 76 (8), 857-864, 2010 | 63 | 2010 |
| Tumor microenvironment composition and severe cytokine release syndrome (CRS) influence toxicity in patients with large B-cell lymphoma treated with axicabtagene ciloleucel R Faramand, M Jain, V Staedtke, H Kotani, R Bai, K Reid, SB Lee, ... Clinical Cancer Research 26 (18), 4823-4831, 2020 | 56 | 2020 |
| An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection J Hernandez, SM Cowgill, S Al-Saadi, D Villadolid, S Ross, E Kraemer, ... Annals of surgical oncology 15, 807-814, 2008 | 43 | 2008 |
| Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer M Poch, ML Hall, A Joerger, K Kodumudi, M Beatty, PP Innamarato, ... Oncoimmunology 7 (9), e1476816, 2018 | 39 | 2018 |
| The changing paradigm of management of liver abscesses in chronic granulomatous disease DM Straughan, KC McLoughlin, JE Mullinax, BE Marciano, AF Freeman, ... Clinical Infectious Diseases 66 (9), 1427-1434, 2018 | 39 | 2018 |
| Isolated limb infusion: a single-center experience with over 200 infusions C O’Donoghue, MC Perez, JE Mullinax, D Hardman, S Sileno, SMH Naqvi, ... Annals of surgical oncology 24, 3842-3849, 2017 | 32 | 2017 |
| Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization G Yang, Z Yuan, K Ahmed, EA Welsh, WJ Fulp, RJ Gonzalez, JE Mullinax, ... Translational Oncology 14 (10), 101165, 2021 | 30 | 2021 |
| Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma WW Tseng, DD Tsao-Wei, D Callegaro, G Grignani, L D'Ambrosio, ... European journal of surgical oncology 44 (6), 810-815, 2018 | 30 | 2018 |
Amod SarnaikAssociate Professor of Cutaneous Oncology and ImmunologyVerified email at moffitt.org
